학술논문
Vedolizumab as first-line biological therapy in elderly patients and those with contraindications for anti-TNF therapy: a real-world, nationwide cohort of patients with inflammatory bowel diseases
Document Type
Article
Author
Source
In: Scandinavian Journal of Gastroenterology . (Scandinavian Journal of Gastroenterology, 2021, 56(9):1040-1048)
Subject
Language
English
ISSN
15027708
00365521
00365521